REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
06/12/2025
Voltar para busca
Dado oficial do USPTO
GENEA BIOMEDX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
47
Atualização mais recente
07/12/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 9, 10, 35, 42
Data de depósito
30/04/2015
Data de registro
06/12/2016
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
31/01/2024
Última transação
07/12/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
707
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
82
Localização do titular
Sydney NSW, AU
Examinador
TWOHIG,SHANNON MARIE
Unidade examinadora
N30
Localização atual
TMO LAW OFFICE 121
Descrição da marca
The mark consists of the stylized wording "GENEA BIOMEDX" to the right of a square that is bisected with a curved line.
Titulares e representantes
Titulares
Genea IP Holdings Pty Ltd
Genea IP Holdings Pty Ltd
Genea Biomedx Pty Ltd
Representantes
Eric Lamb Frost Brown Todd LLP
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 10Classe 35Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
human cell productspluripotent and differentiated human cells and stem cells for medical purposes and clinical usebioassays and cell culture media for use in medical applications; biological and chemical products and substances for medical usebiological and chemical preparations to support growth of human cells and embryoscell culture media for medical or clinical usechemical reagents for medical or clinical use; preparations for the diagnosis of pregnancy; preparations for the diagnosis and/or treatment of infertility and other disorders relating to fertility and human reproduction
Classe 9
Scientific and laboratory apparatusinstruments and equipmentincubators and parts and fittings therefor used to support development of human embryoshuman reproductive tissuehuman spermhuman blastocysts or human oocytesall being for scientific or laboratory use; scientific and laboratory apparatusinstruments and equipmentapparatusinstruments and equipment and parts and fittings therefor for vitrificationcultivationcryopreservationwarming and thawing of human blastocystshuman reproductive tissuehuman spermhuman oocytes or human embryosall being for scientific or laboratory use; scientific and laboratory apparatus instruments and equipmentequipment for identifyingseparatingextracting and processing human sperm or human oocytesall being for scientific or laboratory use; scientific and laboratory apparatusinstruments and equipmentequipment for monitoring the developmentcultivationcryopreservationwarming or thawing of humanembryoshuman reproductive tissuehuman spermhuman blastocysts or human oocytesall being for scientific or laboratory use; scientific and laboratory apparatusinstruments and equipmentequipment for storing or preserving human embryoshuman reproductive tissuehuman spermhuman blastocysts or human oocytesall being for scientific or laboratory use
Classe 10
Surgical and medical apparatus and instruments for use in general surgical or medical procedures; surgical and medical equipment in the nature of incubators and parts and fittings therefor for in vitro fertilization or treatment of infertility and other disorders relating to fertility and human reproduction; surgical and medical equipment in the nature of apparatusinstruments and equipment for vitrificationcultivationcryopreservationwarming and thawing of human blastocystshuman reproductive tissuehuman spermhuman oocytes or human embryos and parts and fittings therefor for surgical or medical purposes; surgical and medical equipment in the nature of equipment for identifyingseparatingextracting and processing human sperm or human oocytes and being for surgical or medical purposes; surgical and medical equipment in the nature of equipment for monitoring the developmentcultivation or cryopreservation of human embryoshuman reproductive tissuehuman spermhuman blastocysts or human oocytes and being for surgical or medical purposes; surgical and medical equipment in the nature of equipment for storing or preserving human embryoshuman reproductive tissuehuman spermhuman blastocysts or human oocytes and being for surgical or medical purposes
Classe 35
Retail and wholesale store services featuring human cell productsbioassays and cell culture media for use in medical or medical research applicationsbiological and chemical products and substances for medical usepreparations for the diagnosis of pregnancypreparations for the diagnosis and/or treatment of infertility and other disorders relating to fertility and human reproductionscientific apparatusscientific instrumentsscientific equipmentlaboratory apparatuslaboratory instrumentslaboratory equipmentsurgical apparatussurgical instrumentssurgical equipmentmedical apparatusmedical instrumentsmedical equipmenteducational materials and programs for use by medicalresearch or scientific laboratoriesclinics and facilitiesmedical practitionersdoctorsclinicianshospitals and medical patients
Classe 42
Scientific and technological servicesscientific researchthe fields of reproductive sciencehuman fertilityhuman reproductionhuman geneticsstem cellsassisted conceptionreproductive geneticsin vitro fertilisationfertility managementembryologyandrologyembryo biopsygenetic diagnosisimmunologyendocrinologyultrasonologythe development of culture media and media formulationsmedia evaluationembryo storagecell cloningfertility testing; scientific research and design services in the fields of reproductive sciencehuman fertilityhuman reproductionhuman geneticsstem cellsassisted conceptionreproductive geneticsin vitro fertilisationfertility managementembryologyandrologyembryo biopsygenetic diagnosisimmunologyendocrinologyultrasonologythe development of culture media and media formulationsmedia evaluationembryo storagecell cloningfertility testing; providing information about scientific research in the fields of reproductive sciencehuman fertilityhuman reproductionhuman geneticsstem cellsassisted conceptionreproductive geneticsin vitro fertilisationfertility managementembryologyandrologyembryo biopsygenetic diagnosisimmunologyendocrinologyultrasonologythe development of culture media and media formulationsmedia evaluationembryo storagecell cloningfertility testing; laboratory servicesmedical laboratoriesclinical laboratories and scientific research laboratories in the field of development of culture media and media formulations; providing information in the fields of medical laboratoriesclinical laboratories and scientific research laboratories relating to reproductive sciencehuman fertilityhuman reproductionhuman geneticsstem cellsassisted conceptionreproductive geneticsin vitro fertilisationfertility managementembryologyandrologyembryo biopsygenetic diagnosisimmunologyendocrinologyultrasonologymedia evaluationembryo storagecell cloningfertility testingthe development of culture media and media formulations
Publicações
Histórico de despachos e eventos da marca no USPTO.
47 publicações encontradas
RNWL
INTERNATIONAL REGISTRATION RENEWED
29/05/2025
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
08/11/2024
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
09/10/2024
INPC
INVALIDATION PROCESSED
09/10/2024
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
01/10/2024
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
31/01/2024
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
31/01/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
29/01/2024
ES71
TEAS SECTION 71 RECEIVED
24/05/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/01/2022
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
06/12/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
15/02/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
18/01/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
18/01/2019
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/04/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/03/2017
FIMP
FINAL DISPOSITION PROCESSED
10/03/2017
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/03/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
06/12/2016
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
02/10/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
20/09/2016
PUBO
PUBLISHED FOR OPPOSITION
20/09/2016
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
31/08/2016
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
31/08/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
31/08/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/08/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/08/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/08/2016
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
08/08/2016
CHLD
CHANGE OF OWNER RECEIVED FROM IB
16/06/2016
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
24/02/2016
GNFR
FINAL REFUSAL E-MAILED
24/02/2016
CNFR
FINAL REFUSAL WRITTEN
24/02/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
20/02/2016
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
19/02/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
19/02/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
19/02/2016
RFNT
REFUSAL PROCESSED BY IB
04/09/2015
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
20/08/2015
RFRR
REFUSAL PROCESSED BY MPU
20/08/2015
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
19/08/2015
CNRT
NON-FINAL ACTION WRITTEN
18/08/2015
DOCK
ASSIGNED TO EXAMINER
12/08/2015
MAFR
APPLICATION FILING RECEIPT MAILED
21/07/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
17/07/2015
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
16/07/2015
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace GENEA BIOMEDX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.